Bolt Biotherapeutics (BOLT) Other Non-Current Liabilities (2020 - 2026)
Bolt Biotherapeutics' Other Non-Current Liabilities was $132,000 in Q2 2026, down 0.8% from $133,000 a year earlier and down 16.5% from the prior quarter.
Bolt Biotherapeutics (BOLT) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
From Q4 2020 onward, Bolt Biotherapeutics has reported Other Non-Current Liabilities for 19 quarters.
- Other Non-Current Liabilities shows a five-year compound annual growth rate of -16.7% (FY2020 to FY2025).
- In earlier years, Other Non-Current Liabilities was $43,000 in FY2023 (+2.4%), $42,000 in FY2022 (-80.0%) and $210,000 in FY2021 (-36.2%).
- Quarterly Other Non-Current Liabilities has moved between $42,000 (Q4 2022) and $217,000 (Q3 2021) over five years.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q1 2026 (growth of 19.7%); the worst was Q4 2022 (a decline of 80.0%).
- Per Business Quant data, BOLT's Other Non-Current Liabilities in the three quarters before Q2 2026 was $158,000 (Q1 2026), $132,000 (Q4 2025) and $133,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Bolt Biotherapeutics | 8.06 Mn | -10.04 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132,000.00 |
| Mar 31, 2026 | 158,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 42,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 204,000.00 |
| Dec 31, 2021 | 210,000.00 |
| Sep 30, 2021 | 217,000.00 |
| Jun 30, 2021 | 233,000.00 |
| Mar 31, 2021 | 321,000.00 |
| Dec 31, 2020 | 329,000.00 |
Bolt Biotherapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BOLT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();